Yanagitani, Noriko

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial

Shiraishi, Y., Kishimoto, J., Sugawara, S., Mizutani, H., Daga, H., Azuma, K., Matsumoto, H., Hataji, O., Nishino, K., Mori, M., et al. (2024) · JAMA Oncology

Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers

Cited by 54

Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer

Koyama, J., Horiike, A., Yoshizawa, T., Dotsu, Y., Ariyasu, R., Saiki, M., Sonoda, T., Uchibori, K., Nishikawa, S., Kitazono, S., et al. (2019) · Journal of Thoracic Disease

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 23

Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis

Shimizu, Y., Matsuzaki, S., Dobashi, K., Yanagitani, N., Satoh, T., Koka, M., Yokoyama, A., Ohkubo, T., Ishii, Y., Kamiya, T., et al. (2011) · Respiratory Research

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedical Imaging and Pathology Studies

Cited by 18

MA06.03 Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study

Liu, G., Yang, N., Choi, C.-M., Ohe, Y., Sugawara, S., Yanagitani, N., De Braud, F., Nieva, J., Nagasaka, M., Zhou, C., et al. (2024) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 4